SELENBP1 and urinary bladder cancer: In the present study, we are the first to show that the reduction of SELENBP1 expression is also a frequent event in human bladder cancer tissues (Fig. 1), but is more likely to occur in patients with non-papillary subtype and advanced TNM stage (Table 1).